AIDS News and Research

RSS

Removing high-grade squamous intraepithelial lesions reduces chances of progression to anal cancer

In a randomized clinical trial with 4,446 participants, known as the Anal Cancer/HSIL Outcomes Research (ANCHOR) study, researchers found that by removing high-grade squamous intraepithelial lesions (HSIL), chances of progression to anal cancer were significantly reduced.

8 Oct 2021

Additional health care support needed to improve medication adherence among people with hypertension

People with hypertension, or high blood pressure, play a key role in whether they use medication appropriately to manage their blood pressure.

7 Oct 2021

What is the frequency of COVID testing to prevent Delta variant transmission?

In a new study published on the medRxiv* preprint server, scientists have used available data on the Delta variant’s viral load to infer its infectiousness and, subsequently, estimate the reduction in its transmission brought about by surveillance testing. The testing, done at different frequencies, was performed on a susceptible population. The cases of both the original Wuhan strain and the Delta variant were considered.

6 Oct 2021

Bone Conduction Kit may enable children and their parents to manage glue ear effectively at home

A wireless kit, comprising headphones, a microphone, and an app might be a cheap alternative to the usual treatment of the common temporary hearing loss in kids, popularly known as 'glue ear,' finds a small study, published in the online journal BMJ Innovations.

5 Oct 2021

Depressed seroconversion in immunocompromised COVID-19 vaccine recipients

Researchers from the University of Singapore have reviewed the data in post-vaccinated immunocompromised patients to examine the effectiveness of these vaccines in these patients.

5 Oct 2021

Listen: California banks on a bold treatment: Pay drug users to stop using

When Billy Lemon was trying to kick his methamphetamine addiction, he went to a drug treatment program at the San Francisco AIDS Foundation three times a week and peed in a cup. If it tested negative for meth, he got paid about $7.

4 Oct 2021

ACTG to present data highlighting a new therapeutic for COVID-19 at the virtual IDWeek 2021

The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that Teresa H. Evering, M.D., M.S., a co-lead investigator (with Eric S. Daar, M.D.) for BRII-196/BRII-198 in the ACTIV-2 study of Outpatient Monoclonal Antibodies and Other Therapies, will present data for the monoclonal antibody combination at the virtual IDWeek 2021 conference, taking place September 29 – October 3, 2021.

30 Sep 2021

New study to evaluate community-based approach to helping children manage asthma symptoms

A new community-based approach to helping children manage their asthma symptoms will launch in up to 40 public, charter, and parochial schools across the Bronx, and enroll 416 students aged 4-12 years old.

29 Sep 2021

Columbia University and partners launch and operate New York City's first Pandemic Response Institute

Through a groundbreaking new award from New York City Economic Development Corporation (NYCEDC), Columbia University – through its Mailman School of Public Health – and a consortium of academic, community, government, and corporate partners will launch and operate New York City's first Pandemic Response Institute (PRI).

29 Sep 2021

Stigmatization prevents many lessons of HIV pandemic from reaching the society

The HIV pandemic hit the LGBTQI+ community particularly early: people who were already stigmatized.

29 Sep 2021

Understanding noise-related hearing loss through changes in RNA levels

A growing number of people are suffering from hearing loss due to exposure to loud noises from heavy machinery, concerts, or explosions.

29 Sep 2021

Novel polyclonal antibody therapy meets the criteria for graduation to phase 3 in ACTIV-2 trial

The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that SAB-185, a novel polyclonal antibody therapy, has demonstrated safety and efficacy in phase 2 that meet the criteria for graduation to phase 3 in the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial (ACTG A5401).

28 Sep 2021

New 'reporter viruses' make it easier to observe SARS-CoV-2 in real time

A version of SARS-CoV-2, the virus that causes COVID-19 disease, has been successfully modified to glow brightly in cells and animal tissues, providing a real-time way to track the spread and intensity of viral infection as it happens in animal models, researchers at Texas Biomedical Research Institute report in the journal The Proceedings of the National Academy of Sciences.

27 Sep 2021

Hepatitis B in newborns is a public health issue in the Pacific islands

The Pacific island nations are falling back on immunization targets, especially those for diseases spread through mother-to-child transmission, according to WHO officials.

24 Sep 2021

A daily pill to treat covid could be just months away, scientists say

Within a day of testing positive for covid-19 in June, Miranda Kelly was sick enough to be scared. At 44, with diabetes and high blood pressure, Kelly, a certified nursing assistant, was having trouble breathing, symptoms serious enough to send her to the emergency room.

24 Sep 2021

How SARS-CoV-2 spike binds to multiple host receptors

Researchers from the Genos Glycoscience Research Laboratory in Croatia have recently investigated the sites that the S protein is capable of binding with.

23 Sep 2021

Study provides clearer understanding of how migraines affect sleep patterns

Adults and children with migraines may get less quality, REM sleep time than people who don't have migraines.

23 Sep 2021

Study paves the way for development of novel delivery systems to suppress HIV

In a new study supported by the National Institutes of Health, researchers used exosomes, tiny nanoparticles capable of being taken up by cells, to deliver novel protein into the cells of mice infected with HIV. The protein attached to HIVs' genetic material and prevented it from replicating, resulting in reduced levels of HIV in the bone marrow, spleen, and brain.

21 Sep 2021

New cell-free antibody generation platform successfully creates neutralizing antibodies effective against SARS-CoV-2

Researchers from the Broad Institute of MIT and Harvard have created a cell-free nanobody engineering platform that can produce antibodies effectively and quickly.

21 Sep 2021

I got a ‘mild’ breakthrough case. Here’s what I wish I’d known.

The test results that hot day in early August shouldn’t have surprised me — all the symptoms were there. A few days earlier, fatigue had enveloped me like a weighted blanket. I chalked it up to my weekend of travel. Next, a headache clamped down on the back of my skull.

20 Sep 2021

AIDS News and Research

Removing high-grade squamous intraepithelial lesions reduces chances of progression to anal cancer

Additional health care support needed to improve medication adherence among people with hypertension

What is the frequency of COVID testing to prevent Delta variant transmission?

Bone Conduction Kit may enable children and their parents to manage glue ear effectively at home

Depressed seroconversion in immunocompromised COVID-19 vaccine recipients

Listen: California banks on a bold treatment: Pay drug users to stop using

ACTG to present data highlighting a new therapeutic for COVID-19 at the virtual IDWeek 2021

New study to evaluate community-based approach to helping children manage asthma symptoms

Columbia University and partners launch and operate New York City's first Pandemic Response Institute

Stigmatization prevents many lessons of HIV pandemic from reaching the society

Understanding noise-related hearing loss through changes in RNA levels

Novel polyclonal antibody therapy meets the criteria for graduation to phase 3 in ACTIV-2 trial

New 'reporter viruses' make it easier to observe SARS-CoV-2 in real time

Hepatitis B in newborns is a public health issue in the Pacific islands

A daily pill to treat covid could be just months away, scientists say

How SARS-CoV-2 spike binds to multiple host receptors

Study provides clearer understanding of how migraines affect sleep patterns

Study paves the way for development of novel delivery systems to suppress HIV

New cell-free antibody generation platform successfully creates neutralizing antibodies effective against SARS-CoV-2

I got a ‘mild’ breakthrough case. Here’s what I wish I’d known.

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News